UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000006457
Receipt number R000007663
Scientific Title Phase II study of Erlotinib Plus Bevacizumab in patients with advanced Non-squamous and Non- Small Cell Lung Cancer harboring EGFR mutation who acquired resistance to prior gefitinib treatment (TAILORED-1 study)
Date of disclosure of the study information 2011/10/03
Last modified on 2011/10/03 11:40:52

No. Disposal Last modified on Item of update
1 Insert 2011/10/03 11:23:28
2 Update 2011/10/03 11:40:52 Public title
Public title
Acronym
Acronym